Chemistry, Department of: Faculty Series
Andrzej Rajca Publications
Accessibility Remediation
If you are unable to use this item in its current form due to accessibility barriers, you may request remediation through our remediation request form.
Document Type
Article
Date of this Version
2012
Citation
J Am Chem Soc. 2012 September 26; 134(38): 15724–15727.
Abstract
We report a molecular design that provides an intravenously injectable organic radical contrast
agent (ORCA) that has molecular r1 ≈ 5 mM−1s−1. The ORCA is based on spirocyclohexyl
nitroxide radicals and polyethylene glycol chains conjugated to a generation 4 polypropylenimine
dendrimers scaffold. The metal-free ORCA has a long shelf-life and provides selectively enhanced
MRI in mice for over 1 h.
Comments
Copyright 2012 Am Chemical Soc. Used by permission.